OvaScience’s Eggpc Technology Recognized By Science As A Top Ten Advancement In Reproductive Medicine

Published: Jan 08, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Science magazine has named OvaScience’s egg precursor cell (EggPCSM) technology, as described in the March 2012 Nature Medicine publication, one of the top ten papers in reproductive medicine. The publication challenged the existing paradigm that women are born with a set number of eggs, and demonstrated for the first time that EggPCs found on the ovaries can be matured into young, healthy eggs. The article by OvaScience co-founder, Jonathan Tilly, Ph.D., was recognized as part of a December 2013 supplement in Science.

Help employers find you! Check out all the jobs and post your resume.

Back to news